Bide Pharmatech Co. Ltd. A (688073) — Cash Flow-to-Debt Ratio
Bide Pharmatech Co. Ltd. A (688073) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2025, meaning its operating cash flow of CN¥28.32 Million could theoretically repay 0% of its total liabilities (CN¥471.40 Million) in one year. See how much free cash does Bide Pharmatech Co. Ltd. A generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bide Pharmatech Co. Ltd. A Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Bide Pharmatech Co. Ltd. A across 6 annual periods. Also explore net asset growth rate of Bide Pharmatech Co. Ltd. A to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bide Pharmatech Co. Ltd. A (2020–2025)
Year-by-year debt coverage analysis for Bide Pharmatech Co. Ltd. A. For market capitalisation and broader financial context, see Bide Pharmatech Co. Ltd. A market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | CN¥28.32 Million | CN¥471.40 Million | ▼ -85.2% |
| 2024 | 0.40x | CN¥158.31 Million | CN¥390.91 Million | ▲ +329.7% |
| 2023 | -0.18x | CN¥-57.39 Million | CN¥325.49 Million | ▼ -267.1% |
| 2022 | 0.11x | CN¥29.87 Million | CN¥283.05 Million | ▲ +145.1% |
| 2021 | -0.23x | CN¥-64.88 Million | CN¥277.27 Million | ▼ -1176.2% |
| 2020 | 0.02x | CN¥3.65 Million | CN¥167.64 Million | — |